SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 12, 2020 for Sudhir Vrundavandas Valia SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 12, 2020 for Raksha Sudhir Valia SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliance Certificate Under Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 2020
Pursuant to the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility were duly maintained by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, a SEBI registered Category-I Registrar & Share Transfer Agent with Registration Number : INR000004058), as specified under regulation 7(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 during the half year ended 31st March 2020. SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Shareholding for the Period Ended March 31, 2020
Sun Pharma Advanced Research Company Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- DEBASHIS DEYDesignation :- Company Secretary and Compliance Officer SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Closure of Trading Window
This is to inform you that, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and the Code of Conduct for prevention of Insider Trading ('The CoC'), the Trading Window for trading by Designated Persons of the Company and their immediate relatives shall be closed with effect from Wednesday, 1st April 2020 till 48 hours after the declaration of financial results of the Company for the quarter and financial year ended 31st March 2020. The date of Board Meeting for declaration of the financial results for the quarter and year ended 31st March 2020 will be intimated in due course. Sun Pharma Advanced Research Company Ltd - 532872 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 13, 2020 for Raksha Sudhir Valia SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Resignation of Director
The Company has received a letter from Mr. Mark Simon, tendering his resignation as an Independent Director of the Company. In his letter, Mr. Simon has conveyed that he intends to pursue an employment opportunity which might constrain his ability to function as an Independent Director of the Company. Further, in compliance with clause 7B (ii) of Part A of Schedule B of the SEBI (LODR) Regulations, Mr. Simon has confirmed that that there is no material reason other than mentioned above for his resignation. The Chairman and Managing Director of the Company has accepted Mr. Simon's resignation and has placed on record the appreciation for the valuable contributions by Mr. Simon during his association with the Company. The Board would appoint a suitable replacement in place of Mr. Simon within the time stipulated under the applicable laws/regulations. Sun Pharma Advanced Research Company Ltd - 532872 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Loss of Share Certificate / Issue of Duplicate Share Certificate. SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to regulation 39(3) of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we hereby inform you that the share certificate as attached detailed, issued by the Company, have been reported by the registered shareholder(s)/ bonafide purchasers to have been lost/ misplaced/stolen.